Where Will Illumina Be in 1 Year?

The stock market is starting off 2020 with a bang, but investors in Illumina (NASDAQ: ILMN) haven't shared in those gains. Despite strong performances by companies in technology, biotech, and the healthcare sector as a whole, Illumina's shares are down 10% since the beginning of the year after the gene-sequencing leader reported better-than-expected results for the fourth quarter and announcing an innovative new line of sequencing systems.

Should Illumina investors expect more of the same lackluster performance in 2020? The market seems to think that the year ahead will be unspectacular for this leading healthcare company, but let's look at where the company will be 12 months from now, when investors and analysts will be looking ahead to 2021.

Image source: Getty Images.

Source Fool.com